NURECA2026-06-10Disclosure1NURECA2026-06-10xbrli:sharesxbrli:pureiso4217:INR
Prohibition of Insider Trading
NURECA LIMITED
General information about company
| Scrip Code | 543264 |
| NSE Symbol | NURECA |
| MSEI Symbol | NOTLISTED |
| Name of the Signatory | Saurabh Goyal |
| Designation of Signatory | Director |
| Place | Chandigarh |
| Date of Filing | 10-06-2026 |
| ISIN Code | INE0DSF01015 |
| Disclosure under Regulation | Regulation 7 (2) |
| Revised Filing | No |
PIT Disclosure
| Sr. No. | Type of instrument | Description of type of instrument (applicable in case of other is selected) | Category of person | Name of the person | CIN / DIN | Securities held prior to acquisition / disposal | Securities acquired / disposed | Securities held post acquisition / disposal | Date of allotment advice / acquisition of shares / sale of shares specify | Mode of acquisition / disposal | Date of intimation to company | Type of contract | Contract specification | Buy | Sell | Exchange on which the trade was executed | Notes |
|---|
| No. of security | % of shareholding | No. of security | Value of security (in Rs.) | Transaction type | No. of security | % of shareholding | From date | To date | Notional value | No. of units (contracts × lot size) | Notional value | No. of units (contracts × lot size) |
|---|
|
| 1 | Equity | | Promoter Group | Nectar Biopharma Private Limited | U24100MH2015PTC314118 | 60842 | 0.63% | 60842 | 14,370,880.00 | Sell | 0 | 0.00% | 09-06-2026 | 09-06-2026 | Off Market | 09-06-2026 | | | | | | | NA | |